Sunshine Biopharma (SBFMW) Other Non-Current Assets (2017 - 2026)

Sunshine Biopharma (SBFMW) reported Other Non-Current Assets of $71740.0 for Q1 2026, down 92.75% quarter-over-quarter from $989572.0 in Q2 2019.

Sunshine Biopharma (SBFMW) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Sunshine Biopharma has reported Other Non-Current Assets for 4 years, with the latest figure at $71740.0 in Q1 2026.

For the quarter ending Q1 2026, Other Non-Current Assets changed N/A year-over-year to $71740.0; the trailing twelve-month figure through Mar 2026 stood at $71740.0 (changed N/A YoY), and the FY2018 full-year result was $989572.0, up 1132.5% from the prior year.
Other Non-Current Assets for Q1 2026 stood at $71740.0, down from $989572.0 in the prior quarter.
The five-year high for Other Non-Current Assets was $71740.0 in Q1 2026, with the low at $71740.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Teva Pharmaceutical Industries	39.97 Bn	36.23 Bn	1.97 Bn	1.79 Bn
2	Zoetis	33.59 Bn	31.65 Bn	1.62 Bn	351.00 Mn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	233.20 Mn
4	Neurocrine Biosciences	16.10 Bn	14.78 Bn	800.70 Mn	73.60 Mn
5	Aurora Cannabis	15.56 Bn	15.47 Bn	21.72 Mn	2.64 Mn
6	Elanco Animal Health	12.04 Bn	11.61 Bn	785.00 Mn	295.00 Mn
7	Alkermes	7.36 Bn	6.84 Bn	-116.06 Mn	59.36 Mn
8	Lantheus Holdings	6.74 Bn	6.24 Bn	230.92 Mn	-
9	Liquidia	6.27 Bn	6.04 Bn	121.79 Mn	3.50 Mn
10	Sunshine Biopharma	-	-	2.18 Mn	71,740.00

Download Data